PeriVision logo — Helping eye doctors save vision with AI, virtual reality and...

PeriVision

Helping eye doctors save vision with AI, virtual reality and the cloud

Founded 2022 Switzerland Lausanne, Switzerland 11 employees Seed Total: $4.95M

General Information

Company Name PeriVision
Founded Year 2022
Location Switzerland Lausanne, Switzerland
Founders / Decision Makers
Team member
Employees 11
Funding Stage Seed
Business Model B2B, SaaS, D2C
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with PeriVision. To contact PeriVision, visit perivision.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Sep 14, 2026

PeriVision launched VisionOne™, a new virtual reality eye testing platform designed to set a new standard for visual fields.

Award Received Sep 10, 2026

PeriVision climbed to #49 in the TOP100 Swiss Startup Awards 2026 by Venturelab, validating their important work in eye care.

About PeriVision

PeriVision is a promising health tech startup founded in 2022 and headquartered in Switzerland. The company is positioned within the critical intersection of healthcare and technology, focusing on addressing the substantial need for innovation in vision care.

Their slogan, "Helping eye doctors save vision with AI, virtual reality and the cloud," succinctly encapsulates their mission. PeriVision tackles the challenge of vision impairment, an issue affecting 2.2 billion people worldwide, with innovative solutions combining AI algorithms, virtual reality, and cloud computing.

Their disease-centric approach first targets glaucoma, optimizing the monitoring of this condition for 80 million patients globally. By enhancing workflow efficiency and clinical insight, PeriVision aims to make a significant impact on eye care provision and outcomes.

The startup received a Fr.2.40M seed investment on 01 September 2025. This investment underscores the confidence stakeholders have in its potential to modernize and significantly improve the digital transformation of eye care.

Taxonomy: vision impairment, AI in healthcare, virtual reality healthcare, cloud computing in medicine, digital transformation eye care, clinical insights eye diseases, glaucoma monitoring, workflow efficiency healthcare, disease-centric approach, eye disease technology, visual function testing, aging population solutions, preventable blindness

Services & Products

VisionOne™ Platform
VR Visual Field Tests
AI-driven Eye Test Optimization
Clinical Study Collaboration
Data Analysis via Cloud

Target Customers

Eye Doctors Clinical Technicians Ophthalmology Clinics Patients with Vision Disorders Healthcare Researchers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Fr.2.40M -
01 Sep 2025
Debt Financing Fr.300.00K 1
Fondation FIT
01 Mar 2025
Support Program Undisclosed 1
SWISS INVESTMENT CORPORATION
01 Jan 2024
Grant $750.00K 1
SWISS INVESTMENT CORPORATION
01 Jun 2023
Support Program Undisclosed 1
SWISS INVESTMENT CORPORATION
01 Jan 2023
Spinout $1.50M 1
University Ventures
01 Jan 2022

PeriVision Alternatives & Competitors

View All Alternatives
PeriVision vs

Our vision is to end preventable blindness using innovative devices, AI, digital platform and last m...

Series B
218 employees
Health Care, Medical Devices

FAQ About PeriVision

Helping eye doctors save vision with AI, virtual reality and the cloud
PeriVision was founded in 2022.
PeriVision is headquartered in Lausanne, Switzerland.
PeriVision has a B2B, SaaS and D2C business model. Its revenue comes from Subscription, Usage Based and Service Fee.
PeriVision has approximately 11 employees.
PeriVision has completed 6 funding rounds, raising a total of $4.95M. The latest funding stage is Seed.
PeriVision offers: VisionOne™ Platform, VR Visual Field Tests, AI-driven Eye Test Optimization, Clinical Study Collaboration, Data Analysis via Cloud.
Top alternatives and competitors to PeriVision include Forus Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PeriVision and Forus Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PeriVision, https://bouncewatch.com/company/perivision-1, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes